Warning Letter — ABS Corporation
The FDA's Center for Veterinary Medicine issued a Warning Letter to ABS Corporation on July 23, 2026, following an evaluation of the firm's compliance status.
This affects ABS Corporation, its regulatory and quality departments, and potentially other stakeholders involved in the manufacturing or distribution of their veterinary products.
A Warning Letter from the Center for Veterinary Medicine typically indicates significant violations of the Federal Food, Drug, and Cosmetic Act. For regulatory teams, this suggests that previous responses to inspectional observations may have been deemed insufficient, potentially leading to further enforcement actions such as seizure, injunction, or debarment if deficiencies are not corrected.
Conduct a thorough internal audit of all veterinary product labels and manufacturing processes to ensure alignment with CVM standards. Ensure all regulatory filings are current and that any previous observations from inspections have been fully addressed and documented.
FDA Warning Letter issued to: ABS Corporation. 07/23/2026 — Center for Veterinary Medicine. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/abs-corporation-732115-07232026
Open in openFDA / FDA.gov